Evotec SE (EVO) Operating Expenses (2009 - 2025)
Evotec SE's (EVO) quarterly Operating Expenses came in at -$51683.5 in Q4 2025, up 3.07% year-over-year from -$50142.0 in Q4 2024, and up 99.9% quarter-over-quarter from -$52.0 million in Q3 2025.
Analysis
Evotec SE (EVO) Operating Expenses (2009 - 2025) Analysis & Trends
Evotec SE has disclosed Operating Expenses across 9 years of filings, most recently posting -$51683.5 for Q4 2025.
- In Q4 2025, Operating Expenses rose 3.07% year-over-year to -$51683.5; the TTM figure through Dec 2025 stood at -$142.9 million (up 39.56% YoY), while the FY2025 annual figure was -$198846.8, up 2.38% from the prior year.
- Operating Expenses came in at -$51683.5 for Q4 2025 at Evotec SE, up from -$52.0 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $44.5 million in Q3 2023 to a low of -$137.2 million in Q4 2023.
- Average Operating Expenses over 5 years is -$43.8 million, with a median of -$41.2 million recorded in 2025.
- Year-over-year, Operating Expenses plunged 88.69% in 2023 and soared 99.96% in 2024.
- Over 5 years, Operating Expenses stood at -$120.6 million in 2021, then advanced by 7.08% to -$112.1 million in 2022, then slipped by 22.38% to -$137.2 million in 2023, then soared by 99.96% to -$53322.9 in 2024, then increased by 3.07% to -$51683.5 in 2025.
- Per Business Quant data, the three most recent Operating Expenses figures were -$51683.5 in Q4 2025, -$52.0 million in Q3 2025, and -$41.2 million in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn | 637.00 Mn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn | 560.51 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn | 228.90 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn | 1.93 Bn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn | 663.40 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn | 78.70 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn | 14.36 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn | 4.98 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | 2.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -51,683.53 |
| Sep 30, 2025 | -51.95 Mn |
| Jun 30, 2025 | -41.17 Mn |
| Mar 31, 2025 | -49.69 Mn |
| Dec 31, 2024 | -53,322.91 |
| Sep 30, 2024 | -49.17 Mn |
| Jun 30, 2024 | -129.60 Mn |
| Mar 31, 2024 | -57.54 Mn |
| Dec 31, 2023 | -137.16 Mn |
| Aug 29, 2023 | 44.47 Mn |
| Jun 30, 2023 | -69.79 Mn |
| Dec 31, 2022 | -112.08 Mn |
| Sep 30, 2022 | 42.30 Mn |
| Jun 30, 2022 | -36.99 Mn |
| Mar 31, 2022 | -35.73 Mn |
| Dec 31, 2021 | -120.63 Mn |
| Sep 30, 2021 | 29.99 Mn |
| Jun 30, 2021 | -29.01 Mn |
| Mar 31, 2021 | -28.83 Mn |
| Dec 31, 2020 | -92.09 Mn |